Requiem for the Me-Too Drug
When I hear public uproar over the price of prescription drugs, my initial urge is to defend the pharmaceutical companies. The average R&D cost for a new molecular entity (NME) […]
When I hear public uproar over the price of prescription drugs, my initial urge is to defend the pharmaceutical companies. The average R&D cost for a new molecular entity (NME) […]
When I hear public uproar over the price of prescription drugs, my initial urge is to defend the pharmaceutical companies. The average R&D cost for a new molecular entity (NME) […]
I’m in the habit of scanning the news throughout the day and bookmarking articles that I don’t have time to read at that moment. Unfortunately, this leads to a bookmarks […]
Whether it’s for a potential new client or an existing one, we, as an industry, often try to achieve their business objectives with a laundry list of our products and […]
So many have written on this topic. I recently read (and highly recommend) a book titled the same, as well as an article in Forbes about the lack of story […]
In advertising, we’re all aware that change is constant. We do our best to take notice and move forward. I’ve recently noticed a change in how agencies attempt to leverage […]
Imagine that you woke up one morning, turned on your local news and heard the following uttered from the newsreader: “a cure for cancer has been found.” Quickly, you turn […]
Well, I have to say one of the biggest recent lifts to my ego was our companies’ (Brandkarma and Core-Create) nominations for two Manny Awards. And while some may be […]
As healthcare marketers, we attempt to gain insight into the minds of our biggest customer—the physician. Unlike consumers, the professional audience chooses to participate actively in healthcare issues and will […]
Now this is our idea of pharma: earlier this winter, a pharmacy by superstar designer Karim Rashid opened in Belgrade, Serbia, and it’s a far cry from your local CVS. […]